Oppenheimer & Co’s Avanos Medical AVNS Stock Holding History

Oppenheimer & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-27,395	Closed	-$1.25M	–	1488
2014 Q4	$1.25M	Buy	+27,395	New	+$1.08M	0.04%	539

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Oppenheimer & Co's AVNS Position: Q1 2015 in Review

Oppenheimer & Co sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 27,395 shares — an estimated $1.25M sold.

Oppenheimer & Co first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $1.25M in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

Oppenheimer & Co reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
Oppenheimer & Co sold 27,395 Avanos Medical shares in Q1 2015, an estimated $1.25M.
Oppenheimer & Co first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
Oppenheimer & Co's Avanos Medical position peaked at $1.25M in Q4 2014.
448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Oppenheimer & Co's 13F filing for Q1 2015, filed 8 May 2015.